Klaus W. Wagner
2019
In 2019, Klaus W. Wagner earned a total compensation of $518K as Chief Medical Officer at Inhibrx.
Compensation breakdown
| Non-Equity Incentive Plan | $144,000 |
|---|---|
| Salary | $360,000 |
| Other | $14,000 |
| Total | $518,000 |
Wagner received $360K in salary, accounting for 69% of the total pay in 2019.
Wagner also received $144K in non-equity incentive plan and $14K in other compensation.
Rankings
In 2019, Klaus W. Wagner's compensation ranked 11,665th out of 13,971 executives tracked by ExecPay. In other words, Wagner earned more than 16.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,665 out of 13,971 | 17th |
Division Manufacturing | 4,720 out of 5,701 | 17th |
Major group Chemicals And Allied Products | 1,863 out of 2,200 | 15th |
Industry group Drugs | 1,606 out of 1,886 | 15th |
Industry Biological Products, Except Diagnostic Substances | 349 out of 389 | 10th |
Source: SEC filing on April 28, 2021.
Wagner's colleagues
We found two more compensation records of executives who worked with Klaus W. Wagner at Inhibrx in 2019.